The importance of evaluating specific myeloid malignancies in epidemiological studies of environmental carcinogens
Abstract Introduction Although myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN) – including chronic myeloid leukemia (CML) – and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are largely clinically distinct myeloid malignancies, epidemiologica...
Main Authors: | K. A. Mundt, L. D. Dell, P. Boffetta, E. M. Beckett, H. N. Lynch, V. J. Desai, C. K. Lin, W. J. Thompson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-07908-3 |
Similar Items
-
The Impact of Epigenetic Modifications in Myeloid Malignancies
by: Deirdra Venney, et al.
Published: (2021-05-01) -
EZH2 in Myeloid Malignancies
by: Jenny Rinke, et al.
Published: (2020-07-01) -
Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology
by: Theodoros Karantanos, et al.
Published: (2021-03-01) -
Implication and Regulation of AMPK during Physiological and Pathological Myeloid Differentiation
by: Arnaud Jacquel, et al.
Published: (2018-09-01) -
The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias
by: Raffaella Pippa, et al.
Published: (2020-02-01)